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Abstract
Provision of antiretroviral treatment (ART) to people living with HIV (PLWH) has increased globally. Research measuring
whether ART restores subjective well-being to ‘‘normal’’ levels is lacking, particularly in resource limited settings. The study
objectives are to compare quality of life and depression symptoms for PLWH on ART to a general community population
and to explore factors to explain these differences, including socio-economic status and the impact of urban or rural
residence. PLWH on ART (n = 263) were recruited from ART delivery sites and participants not on ART (n = 160) were
recruited from communities in Wakiso District, Uganda. Participants were interviewed using the translated World Health
Organisation Quality of Life brief measure, the Hopkins Symptom Checklist depression section, and questions about socio-
economic status, residence as urban or rural and, for PLWH on ART, self-reported adherence and use of HIV counselling.
Compared to the community sample and controlling for location of residence, PLWH on ART had significantly higher quality
of life (QOL) for physical, psychological and environment domains, but not the social domain. These differences were not
due to socio-economic status alone. Depression scores were significantly lower for PLWH on ART. Both comparisons
controlled for the effect of location of residence. People on ART self-reported high adherence and the majority had used HIV
counselling services. Our findings show better QOL amongst PLWH on ART compared to a general community sample,
which cannot be explained solely by differences in socio-economic status nor location of residence. The general community
sample results point towards the challenges of life in this setting. Access to health services may underpin this difference and
further research should explore this finding, in addition to identification of psychological mechanisms that relate to better
QOL. ART provision infrastructure has clear benefits. Further work should consider sustainability and replication for other
health conditions.
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Introduction
The impact of antiretroviral therapy (ART) on the health of
people living with HIV (PLWH) is well documented [1–4]. Over
the last decade, the measurement of the effects of ART on quality
of life (QOL) has been increasingly a focus of research,
predominantly in industrialised countries [5–7]. As the roll-out
of ART has increased in resource-limited settings, researchers
have also begun to explore the impact of ART on QOL and more
general well-being in those settings. A literature review of these
studies show that PLWH on ART have significantly better
physical health, emotional well-being, mental health and daily
function compared to PLWH who are not on ART [1]. Similarly,
ART is associated with lower depression compared to PLWH not
on ART; as people’s health and hope are restored, they can work
again and engage socially [8]. However it remains unclear the
extent to which PLWH on ART achieve similar well-being as
people in the general community who are not on ART.
A better understanding of the well-being for PLWH on ART,
compared to the general population, is important first as this
provides an indicator of needs and intervention success. Identifi-
cation of either low QOL or high depression may point to ongoing
unmet needs. Second, achievement of good QOL over longer
term may provide a motivator for ongoing adherence to ART
[9,10]. Finally, depression specifically is highly relevant owing to
the global burden of the condition [11]. High depression may
indicate a treatment need of high relevance to PLWH as
depression is a barrier to adequate ART adherence [12].
QOL and depression are affected by a number of factors,
including gender, age, religious beliefs and socio-economic status
(SES) [13]. SES is more strongly associated to QOL in resource-
limited settings [14], such as Uganda. SES may impact QOL
through access to healthcare and fulfilment of basic needs [15].
The American Psychological Association draws researchers’
attention to the importance of SES in relation to HIV/AIDS,
advising considering SES particularly in research around well-
being [16]. Differences in quality of life related to health may be
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mediated by SES: the impact of HIV on QOL may be explained
by differences in SES associated with health status, such as
inability to work owing to poor health.
While treatment can make HIV a manageable chronic
condition [17] and may allow people to ‘‘resume relatively normal
lives’’ [1,9], there is limited information on the QOL and
depression of PLWH on ART compared to a general community
sample. Subjective QOL is not easily predicted by health status, as
people may psychologically adapt to changes in health [18].
Additionally, in some resource-limited settings where substantial
donor funding has been allocated to HIV services compared to
other health services, it is possible that PLWH on ART have
access to better counselling support and treatment than the general
population [19,20], as well as new sources of social support at
clinics, such as meeting new people and involvement with HIV
related community groups [21]. These resources may generate
positive QOL effects compared to others in the general
population.
ART could mean that PLWH continue to experience QOL
below that of a general community sample, as they are still living
with a serious condition and may experience long-term reduced
health or side-effects [22], social exclusion or depression owing to
losses experienced, and reduced life-expectancy [23]. Alternative-
ly, ART could mean that PLWH experience QOL and depression
at the same level as the general community sample, as their health
may be returned to a more ‘‘normal’’ level with minimal side
effects [24], health may mean a return of ability to work [25], signs
of illness may be less visible meaning reduced concerns around
stigma, and counselling and psychological adjustment may help
maintain mood [9,26]. Finally, ART could mean that PLWH
experience higher QOL and less depression than the general
community, as they may have access to new social support and
health care services as a result of being HIV positive. Counselling
or social support may provide new perspectives on life and skills
that enhance well-being and psychological adjustment [9,27]. This
may be particularly relevant in a resource limited setting, where
access to services and care may be limited for the general
population. Both differing levels of resources and the effect of
psychological adjustment and coping render it difficult to predict
QOL in PLWH on ART.
Reviewing the evidence of the impact of ART on PLWH
globally, a limited number of studies have compared QOL or
depression between PLWH on ART and a general sample.
Typically studies report higher depression in those with HIV than
without [28,29], although ART is linked to reduced depression in
PLWH [24]. Lower QOL is reported in those with HIV compared
to a general population sample, for example comparing PLWH on
ART to a general sample in Vietnam [30] and in Malawi [31].
These studies include either people on ART for a short duration or
made no selection based on ART duration. The reviewed research
leaves questions of the impact of duration of treatment longer than
12 months unanswered. Notable exceptions to the pattern of worse
outcomes in PLWH are recent findings from Uganda and South
Africa, which showed greater subjective QOL and functional
ability in older (aged over 50 years) PLWH on ART compared to
those without HIV, explained in part by better access to
healthcare for PLWH [20,21,32]. It is of interest whether these
findings only apply to older adults.
The principal aim of this paper is to compare well-being for
PLWH on ART to a general community sample in the resource-
limited setting of Wakiso, Uganda. Specifically, subjective QOL
and an indicator of depression are compared between PLWH who
have been on ART for at least one year and a general community
sample. In addition, the potential mediating role of SES is
addressed.
Methods
Study site
Data were collected between January 2011 and March 2012 in
Wakiso District, central Uganda. Three types of ART delivery
sites in the District were selected to recruit participants: the HIV
clinic at the government hospital in Entebbe; three government
health centres outside Entebbe that have referral links to Entebbe;
and the Entebbe branch of a well-established non-governmental
organisation, The AIDS Support Organisation (TASO).
Wakiso District, which encircles the capital city Kampala, was
selected as the site for ease of access to the study population (the
research project and team were based at the Medical Research
Council/Uganda Virus Research Institute [MRC/UVRI], En-
tebbe) and because of the presence of established government and
non-government treatment providers. This region includes both
more urban and more rural communities; however, this distinction
is not a simple one as there is substantial peri-urban development
and people may travel between communities.
Sample
For the PLWH on ART sample, participants must have been on
ART for more than one year to be eligible. A list of eligible
patients was compiled for each facility, which was then stratified
by age and gender. The sample was selected randomly from the
ART delivery sites using systematic random sampling intervals.
The participants from the general population were randomly
recruited from nearby villages, first stratified by gender, using
resident lists from communities which had been part of an earlier
unrelated MRC/UVRI study. It must be noted that HIV status
was not determined in the control sample. The data collected
herein are part of a wider study ‘‘Life on antiretroviral therapy:
People’s adaptive coping and adjustment to living with HIV as a
chronic condition in Wakiso District, Uganda’’, funded by the UK
Economic and Social Research council (grant number RES-062-
23-2663). Sampling for the control group was completed using an
existing list of residents in several communities held by the Medical
Research Council from previous studies. Sampling was not
stratified by age nor by urban vs rural variations.
Data collection measures
Measures assessed quality of life, mood and socio-economic
status. In addition, participants provided information about
location of residence as urban or rural, their age, gender,
household size, years of education, religion, marital status, use of
medication and HIV counselling and self-reported adherence over
the last three days and if they had missed pills more than three
times in the last month [33].
The fifteen item depression section of the Hopkins Symptom
Check List (DHSCL) [34] was used. Scores range from 15 to 60,
with higher scores indicating more symptoms of depression. This
measure is commonly used as a screening tool for depression and
has been validated for use in a range of cultures [35–37]. It is
validated for use in Uganda in the Luganda language and has
good predictive validity to detect depression and good internal
consistency [38]. The measure has a cut-off score to indicate likely
presence of depression. The Hopkins checklist has been researched
to identify a cut-off point that indicates the likely presence of
depression. This cut-off point has been found to be related to
context, culture and measurement version. For example a mean
score greater than 1.75 is used in Norway [39] and 1.03 for
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pregnant women with HIV in Tanzania [40]. Studies using the
Ugandan version of the measure (as used in this study) have
validated and used a cut-off of above 30 (or an individual’s mean
score of 2) to indicate probable depression [41,42]. This same
method is used here to allow comparisons to other studies in
Uganda.
To assess quality of life, the World Health Organisation (WHO)
Quality of Life measure the WHOQOL-BREF was used [43].
Twenty-six items assess four domains of quality of life: 1) physical
health, 2) psychological, 3) social relationships and 4) environment.
Higher scores indicate better quality of life. Domain scores range
from 4–20. This measure was selected as it provides an estimate of
quality of life extending beyond health-related quality of life alone
and has been shown to be valid cross-culturally [43]. The measure
was translated into Luganda using the WHO guidelines and
achieved adequate validity and internal consistency, comparable
to other translated versions [44].
Participants were also asked to complete items forming a socio-
economic status (SES) score. SES scores were created from
variables of owning one’s home, having electricity, having piped
water, having a good toilet (flush), having a house with a good roof
(iron/tile) and having a paid job (skilled manual labour, formal
business, professional or service job). The SES scores were created
through inverse frequency weighting, where rarest items are given
greater weighting in the score (weights for each variable are
derived by dividing total sample size by number of participants
who have the item, these are then summed to create the overall
score). Higher scores indicate greater assets and socio-economic
status.
Ethical considerations
Ethical approval for the study was obtained from the Uganda
Virus Research Institute and the University of East Anglia, UK.
Overall approval was granted by the Uganda National Council for
Science and Technology. Informed consent was gained from
participants in written format, or witnessed oral consent was used,
endorsed by thumb print. These consent procedures were ethically
approved.
Analysis
Statistical data were analysed using PASW Statistics SPSS
version 18. Differences between the characteristics of the HIV and
control group were compared, using t-tests or the appropriate non-
parametric equivalent (Mann-Whitney U). ANCOVA was used to
compare depression and QOL scores between the groups.
ANCOVA was chosen to covary for any variables where there
were significant differences between the groups’ characteristics.
ANCOVA was only conducted after checking for homogeneity of
regression for the covariate at each level of the independent
variable. Homogenity of regression was assessed by calculating the
interaction terms for the independent variable and covariate.
Effect sizes for differences in relation to HIV group were
calculated using a standard method to include consideration of
the variance of the covariate [45].
Correlation analysis was performed using Pearson’s r, as data
were found to be normally distributed, and was used to explore the
relationship between variables. Group sizes were unequal com-
paring the HIV group and control group; therefore, corrections
for unequal variances are reported where necessary (reflected in
the reported degrees of freedom). Effect sizes are included
(Cohen’s d) where appropriate.
Mediation analysis was used to test the significance of the
indirect effects of the independent variable or ‘‘IV’’ (HIV group or
control group) on the dependent variables or ‘‘DV’’ (WHOQOL
domains) through a potential mediator or M (socio-economic
status). Mediation analysis addresses the degree to which
differences between the groups’ QOL may be due to the impact
of SES. The mediated or indirect effect is the product of effect of
IV on M (a) and the effect of M on the DV (b), partialling out the
effects of the IV on the DV [46]. The direct effect (c9) is the
relationship between IV and DV, taking account of the mediated
effect. The total effect (c) is the total relationship between IV and
DV. Mediation analysis used bootstrapping to estimate the
indirect (or mediated effect) size, which were considered significant
when the 95% confidence interval did not include zero [47,48].
The SPSS Macro was used to calculate the model components
[49]. There is no agreed upon way of calculating how much of the
variables effect is due to mediation [50]. The method used here is
to calculate the proportion of the total effect that is mediated
(creating a percentage by dividing indirect effect by total effect,
subtracting this from one and multiplying by 100).
Results
Demographic differences between HIV and control
group
Table 1 shows the comparison between demographic data for
the PLWH on ART group or ‘‘HIV group’’ (n = 263) and control
group (n= 160). Prior to exploring any differences in outcomes of
depression and quality of life scores between the groups, it was
essential to ensure that the groups were comparable in terms of
other variables that may have an impact on these outcomes.
Comparisons of marital status (x2(2) = 5.24 p= 0.07), gender
(x2(1) = 3.16 p= 0.076), religion (x2(1) = 0.21 p= 0.65), education
level (x2(2) = 1.23 p= 0.54) and age (t(239.5, equal variances not
assumed) = 0.016 p= 0.99) revealed no significant differences
between HIV and control group. As such, there is no requirement
to control for these variables when comparing QOL or depression
scores for the two groups.
Total household size was significantly different (t(283) = 2.309,
p = 0.022, mean difference 0.72, 95% CI 0.10–1.33). When
household size was correlated with WHOQOL scores and
depression scores, only correlation with the WHOQOL psycho-
logical domain (domain 2) was significant (r =20.1, p = 0.042).
This was a weak correlation. There were significant differences in
urban compared to rural residences of the two groups, although
this division is a simplification as there is peri-urban development.
Those in the HIV group were more likely to be living in urban
regions than those in the control (x2(1) = 43.357, p,0.0001). As
such, comparisons between HIV group and depression and
WHOQOL outcomes included location of residence as a
covariate.
Socio-economic status (SES) was significantly different between
the two groups (t(421) = 2.589, p = 0.01). SES was significantly
higher for people with HIV, although this was a small difference
(effect size d=0.26). SES correlated significantly with depression
(r =20.11, p= 0.031). The correlations between SES and physical
health (WHOQOL domain 1, r = 0.10, p= 0.035), WHOQOL
psychological (domain 2, r = 0.14, p= 0.003) and environment
(WHOQOL domain 4, r = 0.20, p,0.001) were significant,
although only demonstrating a weak relationship. Mediation
analysis was conducted to take into account the impact of SES on
group differences for the WHOQOL domains and depression
symptoms. Although social relationships (WHOQOL domain 3)
did not correlate significantly with SES (r = 0.09, p = 0.052),
mediation analysis was conducted for completion.
Quality of Life and Depression for People on ART
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ART and HIV counselling use in HIV group
All 263 participants in the HIV group were taking ART at the
time of the study, having started ART more than one year prior to
the start of the study. Of the HIV group, 250/263 (95.1%) had
received HIV counselling. Self-reported adherence revealed 19
participants (7.2%) reported missed pills in the last 3 days and 12
(4.6%) reported having missed their pills more than three times in
the last month.
Comparing depression between HIV and control group
Mean scores on the DHSCL were calculated by group. The
HIV group’s mean score was 22.0 (s.d. 5.50), compared to 24.9
(s.d. 6.44) for the control group. The mean difference is 22.92
(95% CI 24.17–21.67), with higher scores in the control group,
indicating more symptoms of depression. There was a significant
difference between the two groups for depression scores after
controlling for the effect of location of residence (F(1,393) = 4.315,
p = 0.038). The effect of the covariate was also significant
(F(1,393) = 4.076, p= 0.044). Taking account of the covariate
variance, the effect size for HIV group was 0.50 (95% CI 0.29–
0.71).
Chi-square test revealed that depression and group were
associated, as x2 (df-1) = 10.82, p= 0.001, phi = 0.161 (small effect
size). The results in Table 2 illustrate how proportionately more
people in the control group are potentially depressed.
Comparing Quality of Life between HIV and control
group
Table 3 provides mean scores on WHOQOL domains by HIV
and control group. ANCOVA revealed that scores were signifi-
cantly higher in the HIV group physical health (WHOQOL
domain 1), after controlling for the effect of location of residence
(F(1,419) = 5.123,p = 0.024). The effect size, taking into account
the covariate, was medium (d= 0.43, 95%CI 0.23–0.63). The
covariate was not significantly related to physical health QOL
(F(1,419) = 3.486,p = 0.062).
For domain 2 (psychological) ANCOVA revealed significantly
higher scores for the HIV group after controlling for the effect of
location of residence (F(1,419) = 6.591,p = 0.011). The effect size,
taking into account the covariate, was large (d = 0.80, 95%CI
0.60–1.00). The covariate was not significantly related to
psychological QOL (F(1,419) = 1.765,p = 0.185).
For domain 3, social relationships, ANCOVA revealed no
significant differences between the groups after controlling for the
effect of location of residence (F(1,419) = 0.73,p = 0.786). The
covariate was not significantly related to social relationship QOL
(F(1,419) = 2.874,p = 0.091).
For domain 4, environment, ANCOVA revealed significantly
higher scores for the HIV group after controlling for the effect of
location of residence (F(1,419) = 14.518,p,0.001). The effect size,
taking into account the covariate, was medium (d= 0.75, 95%CI
0.55–0.95). The covariate was not significantly related to
environment QOL (F(1,419) = 2.550,p = 0.111).
Mediation analysis: HIV group and WHOQOL in relation
to SES
Mediation analysis was completed to explore the degree to
which SES is affecting the relationship between case and quality of
life or depression symptoms. In all cases, the effect of HIV group
(independent variable) on the mediator SES was 1.0869. Table 4
provides the summary analysis.
For all comparisons, the relationship between HIV group (case
or control) and the WHOQOL domain or depression remained
significant when the effect of SES was accounted for: there is no
full mediation of HIV group and QOL or depression by SES.
Table 1. Demographic details of the HIV and Control groups.
Variable HIV (n=263) CONTROL (n=160) p value
Mean Age in years (s.d.) 39.8 (9.76) 39.8 (15.22) 0.99
Mean number of people living in household (s.d.) 4.6 (2.68) 5.3 (3.33) 0.022
Socio-economic status (s.d.) 6.4 (4.32) 5.3 (3.96) 0.01
Frequency (%) Frequency (%)
Urban 113 19 ,0.0001
Rural 150 141
Number female 177 (67.3) 94 (58.8) 0.076
Education level
None 32 (12.2) 17 (10.6) 0.54
Primary 144 (54.8) 93 (58.1)
Junior 3 (1.1) 4 (2.5)
Senior school 62 (27.3) 40 (25.0)
Further education 12 (4.6) 6 (3.8)
Religion
Christian 226 (85.9) 140 (87.5) 0.65
Muslim 37 (14.1) 20 (12.5)
Marital status
Single 60 (22.8) 27 (16.9) 0.07
Married 155 (58.9) 112 (70.0)
Other 48 (18.3) 21 (13.1)
doi:10.1371/journal.pone.0105154.t001
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There was only partial mediation by SES for WHOQOL 2
(psychological) and 4 (environment) domains. However, the effect
of SES on the HIV group to QOL relationship was very small.
The proportion of the total effect that was mediated was calculated
(Table 4). This illustrates the minimal proportion of the relation-
ship between HIV group and QOL that was found to be mediated
by SES, with between 3.6 and 5.9% of the relationship between IV
and DV mediated by SES.
Discussion
Compared to a general population sample, greater QOL was
seen for PLWH on ART for physical, psychological and
environment domains after controlling for the effect of location
of residence. Social relationship (WHOQOL domain 3) scores
were not significantly different in relation to group. Although
socio-economic status was higher in the PLWH on ART, this
accounted for at most 6% of variance in QOL scores. Mean
depression scores (after controlling for the effect of location of
residence) and number of people reaching a threshold for possible
depression diagnosis were lower for PLWH on ART. PLWH on
ART were found to achieve better well-being than the general
community sample.
At first glance these results seem counter-intuitive: that people
with a chronic, incurable illness should have better QOL and
lower symptoms of depression than the general sample. One
possibility is that these results may tell us about the lives of the
general sample in Uganda. Many people live in harsh economic
and social conditions, and experience living costs that outstrip
income [51], and gender inequalities can make women’s lives and
relationships particularly difficult [26]. Access to affordable
essential services remains a problem for many and PLWH on
ART appear to have better access to these services.
The HIV sample reported generally high levels of adherence.
Self-reported adherence was used, and this may be an inaccurate
estimate [52]. Most of the HIV sample had received HIV
counselling (although the quality of this is unknown). Other studies
show high adherence levels on ART, where available, in sub-
Saharan African settings [53,54]. The QOL and depression results
presented here are therefore for a sample of people who appear to
be adhering to ART and using services. A different pattern of
results may be observed comparing PLWH on ART with lower
adherence or with lower access to counselling services. Adherence
to ART and the impact of ART on QOL and depression may
change as the length of time a person is taking ART increases [55].
Longitudinal studies should explore how QOL and depression
may alter over time and taking into account levels of adherence.
This study is one of the first studies in sub-Saharan Africa to
provide a direct comparison between an HIV and non-HIV
group, showing the rates of depression for the general population
are higher. QOL scores, if viewed as a percentage of scale
maximum, ranged across the domains from 71% to 83% for
PLWH on ART and 62% to 74.5% for the general sample. These
ranges are similar to findings that QOL among non-western
populations is generally around 60–80% of scale maximum [56].
Although there were significant differences in depression scores
overall, the two groups’ mean depression scores were not clinically
different (the means for both groups were below the clinical cut-
off). However, we found significantly more people scoring above
the cut-off for likely depression in the general sample as compared
to the PLWH on ART group. Typically studies find higher
depression in PLWH compared to the general population;
however, the findings here may reflect the positive impact of
ART and counselling. Twenty-one percent of participants in the
control sample reached DHSCL scores indicating potential
depression, compared to only 9.6% of the HIV sample. Previous
research found similar rates of depression symptoms with a
national prevalence in Uganda of 29.3% [42] and 8.1% in an HIV
sample [41]. As the rate of attendance at HIV counselling was very
high in our sample, it was not possible to explore any effect of
counselling on reported mood.
PLWH were receiving counselling, care and treatment from
specialised HIV services provided by the state and non-govern-
mental organisations, notably TASO. HIV service infrastructure
has received a great deal of investment since 2004/5, substantively
enhanced by donor funding. These services may impact QOL
domains, including offering access to health care (environment
domain) and benefits of health care (physical). In contrast the
sample from the general population are unlikely to have been
accessing specialised treatment and counselling services.
Table 2. Indicated depression by HIV or control group.
Depression indicated HIV group (%) Control group (%)
Yes 24 (9.6) 31 (21.1)
No 226 (90.4) 116 (78.9)
doi:10.1371/journal.pone.0105154.t002
Table 3. WHOQOL Scores by HIV and Control group.
WHOQOL Domain
HIV group mean
(s.d.)
Control group mean
(s.d.) Mean difference 95% CI of mean difference Effect size (d)
1 Physical health 14.4 (2.15) 13.3 (3.17) 1.09* 0.54–1.65 0.43
2 Psychological 16.6 (1.80) 14.9 (2.52) 1.69* 1.24–2.13 0.80
3 Social relationships 14.6 (2.75) 14.0 (3.16) 0.65 (n.s.) 0.08–1.23 -
4 Environment 14.2 (2.04) 12.4 (2.74) 1.74** 1.24–2.23 0.75
** indicates significantly different at p,0.01,
* indicates significance at p,0.05, based on ANCOVA results. Reported effect sizes take into account the variance relating to the covariate (location of residence).
doi:10.1371/journal.pone.0105154.t003
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Inequalities of service provision for PLWH compared to other
conditions or the general population have been found elsewhere
[57], and a study in South Africa recently found greater QOL in
older adults with HIV compared to those without HIV, explained
by better access to healthcare for PLWH [20]. ART facilities
provide something akin to ‘‘islands of excellence in seas of under
provision’’ [58]. Individuals in both the case and control groups
live in difficult circumstances and this study did not collect detailed
data regarding service access. However, through contact with
ART clinics, PLWH had access to a service which gave them the
opportunity to talk about their problems in counselling sessions or
with their in-group of PLWH. This may relate to the higher
reported QOL and should be investigated in further research.
Research exploring psychological adjustment and the concept of
‘‘post-traumatic growth’’ suggests that following health shocks
and/or treatment, people may experience a renewed sense of well-
being [59]. Gratitude for a new chance at life, a refreshed sense of
priorities and a shift in standards against which QOL is judged can
all lead to increased subjective QOL following illness [60]. Studies
with PLWH in various settings, including Uganda, have found
descriptions of this renewed sense of meaning and gratitude
[61,62]. It may be that these adjustment processes underpin
observed differences, together with different access to resources.
It must be noted that not all PLWH on ART experience good
QOL. Identification of people with high reported QOL could be
used as peer counsellors to support those who are faring less well
on ART or could be used to help motivate those who are refusing/
struggling with adherence to ART. The lower QOL and lower
mood in the community sample also suggests a need for provision
of psychosocial intervention more widely. Greater understanding
of the factors contributing to outcomes in the general community
is required to help target any such intervention and explore wider
policy development regarding improvement of well-being.
Limitations
This study has several limitations. Although not statistically
significant, there were more women and single people in the
PLWH on ART group. Further research could explore the relative
relevance of these variables to well-being outcomes.
ANCOVA was conducted to take into account the covariate of
location of residence. The urban-rural dichotomy does not take
into account the many differences between the sites, where
development initiatives have led to the provision of services in the
rural environments and infrastructure that may be more similar to
a peri-urban environment. Additionally, although location of
residence may be in a more urban area for example, work may
take place in a more rural environment or vice versa. As such, a
more detailed examination of the impact of participants’
environment would be of benefit.
Although SES was measured with a scale specifically designed
for this population, SES is difficult to measure. The measure here
included assets and employment items. Alternatives such as a
longer assets index or measure of expenditure versus income may
have revealed different results.
Self-reported adherence was used to estimate adherence.
Adherence is difficult to measure accurately and alternative,
objective or more detailed measures of adherence should be
included in future research. In addition, data relating to
counselling only concerned attendance at counselling. Further
research should consider the quality and content of this
intervention to properly understand its effect on QOL and
depression.
It is probable that some of the general population sample are
HIV positive and untreated, because HIV prevalence is estimated
at 7.3% [63] and many people are un-tested. It was not possible to
account for this in the data analysis. No data were collected
around objective health measures or types of treatment, therefore
it is not possible to know the extent to which differences in health
QOL were due to better health in the ART group. It is well known
that although people with poor health typically have lower QOL
than those without health problems [43], the relationship between
health status and QOL is complex, particularly in relation to
chronic conditions [64]. Further research should explore the
relative roles of objective health indicators and psychological
adjustment in relation to QOL judgements. The generalizability of
findings is unclear, although our results add to an emerging
evidence base in sub-Saharan African nations were HIV treatment
is accessible that shows better well-being amongst PLWH (on
ART) compared to a general sample [20,21,32].
Conclusions
PLWH on ART were experiencing higher QOL and lower
depression scores than the general community sample. The precise
mechanisms driving these results need to be investigated. It may be
that PLWH on ART experience better health than the control
group, particularly as this sample reported good adherence.
PLWH on ART may have better access to healthcare resources
than the general community and may receive not only ART but
also treatment for other illness, for example, access to antibacterial
medications which treat common infections. As such, access to
ART may also provide better access to healthcare overall. Further
research could directly explore and measure these mechanisms to
quantify their impact on QOL and depression. The needs of the
Table 4. Summary of Mediation analysis of socio-economic status and the relationship between HIV case and WHOQOL domains
(Unstandardised co-efficients are shown).
Dependent variable
Direct effect of HIV
group on DV (c9) Indirect effect (ab)
95% CI of indirect
effect Total effect (c) Proportion %
Depression 2.7895** 0.1301 20.3882–0.008 2.9196** 4.45609
WHOQOL 1 (Physical health) 1.0404** 0.0534 20.0030–0.1698 1.094** 4.89945
WHOQOL 2 (Psychological) 1.6267** 0.0587* 0.0078–0.1607 1.685** 3.45994
WHOQOL 3 (Social relationships) 0.5903* 0.0619 20.0016–0.1963 0.6522* 9.49095
WHOQOL 4 (Environment) 1.6338** 0.1018* 0.0241–0.2316 1.736** 5.88710
* significant at p,0.05.
**significant at p,0.01 Proportion calculated as (12(c9/c))*100.
doi:10.1371/journal.pone.0105154.t004
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general community sample and factors associated with their lower
QOL also require further research and potential intervention.
As HIV care is rolled out to lower level health centres in
Uganda and elsewhere and gradually integrated into the general
health system, it is useful to reflect on the particular benefits that
PLHW in our study may have derived from the infrastructure that
has been put in place because of HIV. People with other chronic
conditions, such as hypertension, might also benefit from such
regular social and medical support, but in a financially resourced
constrained world the provision of such services may decline, with
consequences for ART adherence as well as the QOL of PLHV.
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